文献
J-GLOBAL ID:201302251323459662
整理番号:13A0565975
遺伝子発現の配列特異的制御のためのRNA誘導プラットフォームとしてCRISPRの転用
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
著者 (24件):
QI Lei S.
(UCSF Center for Systems and Synthetic Biology, Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
QI Lei S.
(Dep. of Cellular and Molecular Pharmacology, Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
QI Lei S.
(California Inst. for Quantitative Biomedical Res., San Francisco, CA 94158, USA)
,
LARSON Matthew H.
(Dep. of Cellular and Molecular Pharmacology, Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
LARSON Matthew H.
(Howard Hughes Medical Inst., Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
LARSON Matthew H.
(California Inst. for Quantitative Biomedical Res., San Francisco, CA 94158, USA)
,
GILBERT Luke A.
(Dep. of Cellular and Molecular Pharmacology, Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
GILBERT Luke A.
(Howard Hughes Medical Inst., Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
GILBERT Luke A.
(California Inst. for Quantitative Biomedical Res., San Francisco, CA 94158, USA)
,
DOUDNA Jennifer A.
(Dep. of Molecular and Cellular Biology, Univ. of California, Berkeley, Berkeley, CA 94720, USA)
,
DOUDNA Jennifer A.
(Dep. of Chemistry, Univ. of California, Berkeley, Berkeley, CA 94720, USA)
,
DOUDNA Jennifer A.
(Howard Hughes Medical Inst., Univ. of California, Berkeley, Berkeley, CA 94720, USA)
,
DOUDNA Jennifer A.
(California Inst. for Quantitative Biomedical Res., San Francisco, CA 94158, USA)
,
DOUDNA Jennifer A.
(Physical Biosciences Div., Lawrence Berkeley National Lab., Berkeley, CA 94720, USA)
,
WEISSMAN Jonathan S.
(Dep. of Cellular and Molecular Pharmacology, Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
WEISSMAN Jonathan S.
(Howard Hughes Medical Inst., Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
WEISSMAN Jonathan S.
(California Inst. for Quantitative Biomedical Res., San Francisco, CA 94158, USA)
,
ARKIN Adam P.
(Dep. of Bioengineering, Univ. of California, Berkeley, Berkeley, CA 94720, USA)
,
ARKIN Adam P.
(California Inst. for Quantitative Biomedical Res., San Francisco, CA 94158, USA)
,
ARKIN Adam P.
(Physical Biosciences Div., Lawrence Berkeley National Lab., Berkeley, CA 94720, USA)
,
LIM Wendell A.
(UCSF Center for Systems and Synthetic Biology, Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
LIM Wendell A.
(Dep. of Cellular and Molecular Pharmacology, Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
LIM Wendell A.
(Howard Hughes Medical Inst., Univ. of California, San Francisco, San Francisco, CA 94158, USA)
,
LIM Wendell A.
(California Inst. for Quantitative Biomedical Res., San Francisco, CA 94158, USA)
資料名:
Cell (Cambridge, Mass.)
(Cell (Cambridge, Mass.))
巻:
152
号:
5
ページ:
1173-1183
発行年:
2013年02月28日
JST資料番号:
A0707B
ISSN:
0092-8674
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)